|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS FILED WITH NOVAMED'S JUNE 30, 2000
QUARTERLY REPORT ON FORM 10-QSB AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS
</LEGEND>
<CIK> 0001036478
<NAME> NovaMed, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 18,000
<SECURITIES> 0
<RECEIVABLES> 278,000
<ALLOWANCES> 0
<INVENTORY> 443,000
<CURRENT-ASSETS> 739,000
<PP&E> 92,000
<DEPRECIATION> 28,000
<TOTAL-ASSETS> 825,000
<CURRENT-LIABILITIES> 777,000
<BONDS> 0
0
0
<COMMON> 16,000
<OTHER-SE> 32,000
<TOTAL-LIABILITY-AND-EQUITY> 825,000
<SALES> 375,000
<TOTAL-REVENUES> 375,000
<CGS> 111,000
<TOTAL-COSTS> 568,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (193,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (193,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (193,000)
<EPS-BASIC> (0.01)
<EPS-DILUTED> (0.01)
</TABLE>
|
|